Compare AstraZeneca plc (AZN) vs Marathon Petroleum Corp (MPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Marathon Petroleum Corp — how do they compare? AstraZeneca plc trades at $158.56 (market cap $250.84B), while Marathon Petroleum Corp trades at $336.13 (market cap $89.95B). The key difference: AstraZeneca plc is far larger — about 2.8× Marathon Petroleum Corp's market cap, and AstraZeneca plc pays the higher dividend (1.97%). Which is the better fit depends on your goals.
| AZN | MPC | |
|---|---|---|
Market Cap | $250.84B | $89.95B |
Sector | Health | Energy |
52-Week High | $209.48 | $336.42 |
52-Week Low | $147.06 | $159.11 |
Enterprise Value | $278.12B | $116.48B |
Dividend Yield | 1.97% | 1.25% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →
